• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氟奋乃静在精神科患者中的单剂量药代动力学变异。

Variation in the single dose pharmacokinetics of fluphenazine in psychiatric patients.

作者信息

Midha K K, Hawes E M, Hubbard J W, Korchinski E D, McKay G

机构信息

College of Pharmacy, University of Saskatchewan, Saskatoon, Canada.

出版信息

Psychopharmacology (Berl). 1988;96(2):206-11. doi: 10.1007/BF00177561.

DOI:10.1007/BF00177561
PMID:3148147
Abstract

The single dose pharmacokinetics of fluphenazine (2 x 5 mg tablets, Prolixin) were studied in 21 drug free male psychiatric patients (12 black, 9 white). Plasma samples were harvested over a period of 48 h while the patients were on a strictly controlled diet. The results showed wide interpatient variations in all pharmacokinetic parameters including Cmax, AUC, apparent oral clearance, and elimination half-life. It was determined for each of these parameters that the geometric mean gave a better estimate of central tendency than the corresponding arithmetic mean and the distribution was skewed and leptokurtotic. There was no significant difference between blacks and whites in any pharmacokinetic parameter examined. Considerable variations and marked undulations in the elimination portion of the plasma concentration versus time profiles were evident, possibly indicating biliary recycling of the drug. These undulations made it difficult to determine elimination rate constants for several of the patients. Hydrolysis or plasma samples from one patient demonstrated that the conjugate(s) of fluphenazine was present in three to four times the concentration of the unchanged drug.

摘要

在21名未服用药物的男性精神病患者(12名黑人,9名白人)中研究了氟奋乃静(2片5毫克片剂,Prolixin)的单剂量药代动力学。在患者严格控制饮食的48小时内采集血浆样本。结果显示,包括Cmax、AUC、表观口服清除率和消除半衰期在内的所有药代动力学参数在患者间存在很大差异。对于这些参数中的每一个,均确定几何平均数比相应的算术平均数能更好地估计集中趋势,且分布呈偏态和尖峰态。在所检查的任何药代动力学参数中,黑人和白人之间均无显著差异。血浆浓度-时间曲线消除部分存在相当大的变化和明显波动,这可能表明药物存在胆汁循环。这些波动使得难以确定几名患者的消除速率常数。对一名患者的水解或血浆样本显示,氟奋乃静的结合物浓度是未变化药物浓度的三到四倍。

相似文献

1
Variation in the single dose pharmacokinetics of fluphenazine in psychiatric patients.氟奋乃静在精神科患者中的单剂量药代动力学变异。
Psychopharmacology (Berl). 1988;96(2):206-11. doi: 10.1007/BF00177561.
2
Comparative bioavailability of two tablet formulations of fluphenazine dihydrochloride in drug-free psychiatric patients.两种盐酸氟奋乃静片剂剂型在未用药精神病患者中的相对生物利用度。
J Pharm Sci. 1990 Jan;79(1):3-8. doi: 10.1002/jps.2600790103.
3
Pharmacokinetic and pharmacodynamic studies on high doses of fluphenazine.高剂量氟奋乃静的药代动力学和药效学研究。
Psychopharmacology (Berl). 1988;94(2):237-41. doi: 10.1007/BF00176852.
4
A pharmacokinetic study of trifluoperazine in two ethnic populations.三氟拉嗪在两个种族群体中的药代动力学研究。
Psychopharmacology (Berl). 1988;95(3):333-8. doi: 10.1007/BF00181943.
5
Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia.临床药代动力学对精神分裂症患者抗精神病药物治疗的影响。
J Psychiatry Neurosci. 1994 Jul;19(4):254-64.
6
Plasma fluphenazine levels measured by high-performance liquid chromatography in patients treated with depot injections.通过高效液相色谱法测定接受长效注射治疗患者的血浆氟奋乃静水平。
Arzneimittelforschung. 1993 May;43(5):509-11.
7
Intersubject variation in the pharmacokinetics of haloperidol and reduced haloperidol.氟哌啶醇和还原氟哌啶醇药代动力学的个体间差异。
J Clin Psychopharmacol. 1989 Apr;9(2):98-104. doi: 10.1097/00004714-198904000-00005.
8
Pharmacokinetics of haloperidol and fluphenazine decanoates in chronic schizophrenia.氟哌啶醇和癸酸氟奋乃静在慢性精神分裂症中的药代动力学
Psychopharmacology (Berl). 1990;101(2):274-81. doi: 10.1007/BF02244140.
9
Simultaneous gas chromatographic determination of diphenylhydantoin, carbamazepin (Tegretol), phenobarbital and primidone in presence of Kemadrin (procyclidine) and Prolixin (fluphenazine) in plasma of psychiatric patients.精神病患者血浆中存在开马君(丙环定)和氟奋乃静时,同时气相色谱法测定苯妥英、卡马西平(痛惊宁)、苯巴比妥和扑米酮。
J Chromatogr. 1978 Aug 1;155(1):182-6. doi: 10.1016/s0021-9673(00)83948-5.
10
An ultrasensitive method for the measurement of fluphenazine in plasma by high-performance liquid chromatography with coulometric detection.一种采用库仑检测的高效液相色谱法超灵敏测定血浆中氟奋乃静的方法。
Ther Drug Monit. 1989;11(3):354-60. doi: 10.1097/00007691-198905000-00022.

引用本文的文献

1
Ethnic differences in the neuroleptic treatment of schizophrenia.精神分裂症抗精神病药物治疗中的种族差异。
Psychiatr Q. 1999 Summer;70(2):163-72. doi: 10.1023/a:1022153403924.
2
Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia.临床药代动力学对精神分裂症患者抗精神病药物治疗的影响。
J Psychiatry Neurosci. 1994 Jul;19(4):254-64.
3
Pharmacokinetic optimisation of the treatment of psychosis.精神病治疗的药代动力学优化

本文引用的文献

1
Fluphenazine, trifluoperazine and perphenazine in Vacutainers.置于真空采血管中的氟奋乃静、三氟拉嗪和奋乃静。
Can Med Assoc J. 1981 Feb 1;124(3):263-5.
2
Fluphenazine blood levels and clinical response.氟奋乃静血药浓度与临床反应。
Biol Psychiatry. 1982 Oct;17(10):1123-30.
3
Fluphenazine pharmacokinetics and therapeutic response.氟奋乃静的药代动力学与治疗反应。
Clin Pharmacokinet. 1993 Sep;25(3):217-36. doi: 10.2165/00003088-199325030-00005.
4
Emergency treatment of psychotic symptoms. Pharmacokinetic considerations for antipsychotic drugs.精神病症状的紧急治疗。抗精神病药物的药代动力学考量。
Clin Pharmacokinet. 1995 Jun;28(6):494-504. doi: 10.2165/00003088-199528060-00007.
5
Differences between antipsychotic drugs in persistence of brain levels and behavioral effects.抗精神病药物在脑内药物水平持久性和行为效应方面的差异。
Psychopharmacology (Berl). 1992;108(3):338-44. doi: 10.1007/BF02245121.
Psychopharmacology (Berl). 1981;73(3):205-10. doi: 10.1007/BF00422403.
4
Therapeutic blood levels of fluphenazine: plasma or RBC determinations?氟奋乃静的治疗血药浓度:血浆还是红细胞测定?
Psychopharmacol Bull. 1984 Winter;20(1):168-70.
5
Kinetics of oral fluphenazine disposition in humans by GC-MS.气相色谱-质谱联用法定量分析人口服氟奋乃静的处置动力学
Eur J Clin Pharmacol. 1983;25(5):709-11. doi: 10.1007/BF00542363.
6
Fluphenazine plasma levels and clinical response.氟奋乃静血药浓度与临床反应。
J Clin Psychiatry. 1984 Sep;45(9):370-3.
7
Biological disposition and metabolic fate of fluphenazine- 14 C in the dog and rhesus monkey.氟奋乃静-14C在犬和恒河猴体内的生物学分布及代谢转归
J Pharm Sci. 1971 Jun;60(6):821-5. doi: 10.1002/jps.2600600604.
8
Serum neuroleptic levels and clinical outcome in schizophrenic patients treated with fluphenazine decanoate.接受癸酸氟奋乃静治疗的精神分裂症患者的血清抗精神病药物水平与临床疗效
J Clin Psychopharmacol. 1985 Jun;5(3):143-7.
9
Effects of smoking on fluphenazine clearance in psychiatric inpatients.吸烟对精神科住院患者氟奋乃静清除率的影响。
Biol Psychiatry. 1985 Mar;20(3):329-32. doi: 10.1016/0006-3223(85)90063-0.
10
Plasma levels of fluphenazine during fluphenazine decanoate treatment in schizophrenia.精神分裂症患者癸酸氟奋乃静治疗期间的血浆氟奋乃静水平。
Psychopharmacology (Berl). 1985;87(1):55-8. doi: 10.1007/BF00431778.